First human test for potential psoriasis drug begins
NCT ID NCT07078695
Summary
This is an early safety study to see how the body handles a single dose of an experimental drug called SHR-1139. It involves 24 healthy volunteers and will check for side effects and measure how long the drug stays in the body. The goal is to gather basic safety information before testing in people with psoriasis.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Linear
Perth, Western Australia, Australia
Conditions
Explore the condition pages connected to this study.